As prices surge, foreign carmakers spotlight US-made budget models

At the 2026 Washington Auto Show, foreign-owned automakers highlighted that roughly 75% of cars they sell in the U.S. have MSRPs at or below $35,000 and noted over $100 billion of investment in U.S. production, showcasing nearly 50 domestically built models. Officials warned that record average new-vehicle prices near $50,000 and a 2025 average vehicle age of 12.8 years—driven by chip shortages, stretched global supply chains and tariff/ trade issues—are depressing affordability and safety, a dynamic likely to depress near-term demand and draw increased policy attention.

Analysis

Market structure: Foreign-headquartered OEMs that manufacture in the U.S. (e.g., Toyota TM, Honda HMC, Stellantis STLA) are positioned to capture price-sensitive buyers because they can offer sub-$35k new vehicles while avoiding import frictions. Domestic OEMs and high-ASP EV specialists (e.g., Tesla TSLA) face a bifurcated market—volume pressure on premium models if affordability becomes the dominant purchase driver, but ability to sustain ASPs short-term if supply remains constrained. Supply/demand: lingering chip and supplier bottlenecks keep downside price rigidity for 3–9 months; meaningful easing in chip lead times or a demand shock (recession raising unemployment >1ppt) would quickly shift the balance and compress ASPs.

Risk assessment: Tail risks include punitive tariffs or EV mandates altering product mix (probability ~10–20% over 12–24 months), a renewed semiconductor shock from geopolitical disruption (10%+ chance), or a credit-led auto sales collapse driving repos up >20% year-over-year. Near-term (days/weeks) policy soundbites matter for sentiment; medium (3–9 months) is when capex and production mix change; long-term (2–5 years) is structural: onshoring and $100bn+ investments cited will lower unit costs by an estimated 5–10% if executed. Hidden dependencies include captive finance health (GM Financial, Ford Credit) and residual values that can amplify loan losses.

Trade implications: Favored trades are long U.S.-built low-cost OEM exposure (TM, HMC, STLA) and selective auto-focused semiconductor suppliers (ON Semiconductor ON) via 3–12 month horizons, financed by short exposure to speculative used-car/retailer props (Carvana CVNA) and overvalued premium EV optionality (small short TSLA delta if valuation stretched). Use call spreads to express exposure to ON (3–6 month) and put spreads on CVNA (3 months) to limit capital. Rotate from retail/used-car exposure into OEMs + auto-chip suppliers over the next 30–90 days as Q1 production updates and chip supply signals arrive.

Contrarian angles: Consensus underestimates how quickly foreign OEM U.S. capacity can flood the affordable segment—if they scale 5–10% share within 12–18 months ASP deflation is realistic, pressuring high-valuation EV names and dealers. Market may be underpricing credit risk in subprime auto ABS; a 200–300bps rise in delinquencies would hit securitized credit materially. Unintended consequence: an affordability push could slow battery/EV penetration, creating a multi-year bifurcation between ICE-focused low-cost OEMs and premium EV specialists.

Key Decisions for Investors

• Establish a 2–3% long basket split equally between Toyota Motor (TM) and Honda Motor (HMC); target 12-month return +15–25%. Use buy-and-hold with a stop-loss if either misses quarterly U.S. retail sales guidance by >5% or if USD/JPY appreciates >6% in 60 days.
• Initiate a 1% tactical long in ON Semiconductor (ON) via 3–6 month 1.5x call spread (ITM to OTM) to play auto-chip onshoring; target +25% upside, exit on realized margin expansion guidance being delayed beyond two consecutive quarters.
• Purchase a 1% notional 3-month put spread on Carvana (CVNA) (protective put 1–2 strike width) to hedge used-car normalization and liquidity risk; take profits if CVNA declines 30% or if monthly retail sales volume stabilizes for two consecutive months.
• Construct a 1% pair trade long Stellantis (STLA) vs short Tesla (TSLA) sized to be beta-neutral (sell TSLA delta to fund STLA exposure) for 6–12 months to exploit low-cost OEM share gains; unwind if STLA guidance falls >10% or TSLA reports delivery growth >10% QoQ.